These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4801679)

  • 21. The effect of a pituitary mammotropic tumor on hepatic microsomal drug metabolism in the rat.
    Wilson JT
    Biochem Pharmacol; 1968 Jul; 17(7):1449-57. PubMed ID: 5690694
    [No Abstract]   [Full Text] [Related]  

  • 22. DIFFERENCES IN HEPATIC DRUG METABOLISM IN VARIOUS RABBIT STRAINS BEFORE AND AFTER PRETREATMENT WITH PHENOBARBITAL.
    CRAM RL; JUCHAU MR; FOUTS JR
    Proc Soc Exp Biol Med; 1965 Apr; 118():872-5. PubMed ID: 14277699
    [No Abstract]   [Full Text] [Related]  

  • 23. The relationship of hepatic drug metabolizing activity to serum esterase activities in the albino rabbits.
    Greene FE; Wade AE
    Pharmacology; 1968; 1(6):363-8. PubMed ID: 5710610
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of 3,4-benzpyrene or gamma-chlordane on the rate of metabolism and acute toxicity of aminopyrine, hexobarbital, and zoxazolamine in the mouse.
    Hansen AR; Fouts JR
    Toxicol Appl Pharmacol; 1968 Sep; 13(2):212-9. PubMed ID: 5726414
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolic drug interactions of trapidil (Rocornal)].
    Borchert HH; Szołomicka-Orfinger I; Pfeifer S
    Pharmazie; 1978 Oct; 33(10):663-8. PubMed ID: 724748
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes of drug effects caused by their metabolism in the liver].
    Remmer H
    Monatsschr Kinderheilkd (1902); 1971 Jul; 119(7):382-8. PubMed ID: 5106564
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction and inhibition of hepatic drug metabolizing enzymes by rifampin.
    Pessayre D; Mazel P
    Biochem Pharmacol; 1976 Apr; 25(8):943-9. PubMed ID: 1267838
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism.
    Robinson JR; Nebert DW
    Mol Pharmacol; 1974 May; 10(3):484-93. PubMed ID: 4852151
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of diphenyl-piperazine compounds and other agents on diphenylhydantoin, zoxazolamine and hexobarbital metabolism.
    Gerber N; Arnold K
    J Pharmacol Exp Ther; 1968 Nov; 164(1):232-8. PubMed ID: 4387047
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on the combination of drugs. VI. Effect of 4-hydroxyantipyrine etheral derivatives on metabolism of aminopyrine, phenacetin, acetanilide, and phenylbutazone].
    Nakayama T
    Yakugaku Zasshi; 1968 Jul; 88(7):847-51. PubMed ID: 5750525
    [No Abstract]   [Full Text] [Related]  

  • 31. [The relationship between the inhibition of protein synthesis and the induction of microsomal enzymes by barbital (author's transl)].
    Kröner H
    Z Klin Chem Klin Biochem; 1973 Jan; 11(1):20-3. PubMed ID: 4804137
    [No Abstract]   [Full Text] [Related]  

  • 32. THE EFFECT OF CODEINE TOLERANCE ON HEPATIC MICROSOMAL DRUG METABOLISM IN THE RAT.
    JOHANNESSON T; ROGERS LA; FOUTS JR; WOODS LA
    Acta Pharmacol Toxicol (Copenh); 1965; 22():107-11. PubMed ID: 14284186
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biochemical knowledge in the anesthesiology. 8].
    Yoshikawa K
    Masui; 1970 Oct; 19(11):1262-70. PubMed ID: 5528950
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic drug metabolism in zinc-deficient rats.
    Becking GC; Morrison AB
    Biochem Pharmacol; 1970 Mar; 19(3):895-902. PubMed ID: 5507694
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inhibition of bacterial luminescence by cytochrome P-450 substrates].
    Ismanlov AD; Baranova NA; Danilov VS; Egorov NS
    Biokhimiia; 1981 Feb; 46(2):234-9. PubMed ID: 7248381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of various choleretics on biotransformation and biliary elimination of low molecular substances].
    Grisk A; Möritz KU; Fermum R; Behrend U; Bär H
    Acta Biol Med Ger; 1971; 27(1):179-94. PubMed ID: 5147429
    [No Abstract]   [Full Text] [Related]  

  • 37. Substrate interaction with P-450 in the hydroxylation of drugs under abnormal physiological states.
    Kato R
    Adv Cytopharmacol; 1971 May; 1():249-55. PubMed ID: 5163246
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitory effect of propylthiouracil-induced hypothyroidism in rat on oxidative drug metabolism.
    Raheja KL; Linscheer WG; Chijiiwa K; Iba M
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(1):17-9. PubMed ID: 2865058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Syndnones as inhibitors of biotransformation].
    Ackermann E
    Acta Biol Med Ger; 1966; 17(4):498-506. PubMed ID: 5983632
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):582-7. PubMed ID: 6149908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.